Divergent Total Syntheses of Flavonoid Natural Products Isolated from Rosa rugosa and Citrus unshiu by Sum, Tze Jing et al.
Synlett Letter / Cluster / New Tools 
Template for SYNTHESIS © Thieme  Stuttgart · New York 2016-03-29 page 1 of 3 
Divergent Total Syntheses of Flavonoid Natural Products Isolated From 
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Abstract The concise and step-economical total syntheses of three 
hydroxyaurones and one polymethoxyflavone from readily available starting 
materials is described. A divergent synthetic strategy was employed, which 
centered on a common chalcone scaffold from which both the aurone and 
flavone frameworks could be accessed through the use of different oxidative 
cyclization methods. These are the first reported total syntheses of these 
biologically interesting compounds. 
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Aurones1 and flavones2 are two sub-classes of the flavonoid 
family of natural products.3 Flavonoids have been found to 
exhibit a diverse array of interesting biological properties such 
as anti-cancer,4 anti-malaria,5 anti-inflammatory,6 anti-oxidant,7 
anti-bacterial8 and anti-fungal9 activities. Unsurprisingly 
therefore, natural flavonoids have attracted considerable 
interest from both the synthetic and medicinal chemistry 
communities.10  
In 2012, Gao et al. reported the isolation and characterization of 
three new aurones, named rugaurones A–C (1–3) from the 
flowers of Rosa rugosa (Figure 1).11 These compounds were 
found to have promising cytotoxic and anti-HIV properties.  In 
the same year, Shin et al. reported the isolation of three 
previously unreported flavonoids from the peels of mature 
fruits Citrus unshiu Marcow (Rutaceae), one of which was 
named 3,6,7,8,2’,5’-hexamethoxyflavone (4).12 These peels have 
been used in traditional Chinese medicine and some isolates 
from C. unshiu have been reported to exhibit anti-proliferative 
effects. Given the interesting biological profiles of compounds 1-
4 (and the diverse array of properties typically associated with 
flavonoids in general) we were interested in a more extensive 
assessment of their biological activities.  In view of the very low 
isolation yields of 1-4 from natural sources, it was thought that 
sufficient amounts of materials for biological screening studies 
could only be secured by total synthesis. Herein, we report the 
first total syntheses of compounds 1-4, which were achieved in 
a step-efficient fashion by the application of divergent and 
concise synthetic strategy.     
 
Figure 1 Naturally occurring hydroxyaurones 1-3 isolated from Rosa rugosa 
and a 5-deoxyflavone (4) isolated from Citrus unshiu. 
Based on our previous work on flavonoid synthesis,13 we 
envisaged a divergent strategy for the construction of natural 
products 1-4 which used a chalcone scaffold (of the general 
form 5) as the key branch point (Scheme 1). It was anticipated 
that both the aurone and flavone frameworks (general 
structures 6 and 7 respectively) could be accessed from 5 by the 
application of different oxidation methods;4 mercury(II) acetate 
mediated oxidative cyclization of chalcones 5 would yield 
aurones 6,1 whereas Algar-Flynn-Oyamada oxidation with H2O2 
under alkaline conditions would furnish the 5-deoxyflavone 
framework 7.4 Based on our previous study,13 it was presumed 
that the chalcone precursors 5 could be easily accessed via a 
Claisen-Schmidt aldol condensation between benzaldehydes 8 
and acetophenones 9.4 
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Scheme 1 Retrosynthetic analysis of the hydroxyaurones 6 and 5-
deoxyflavone 7.  
The total syntheses of rugaurones A–C (1–3) was achieved by 
the application of this divergent synthetic strategy (Schemes 2 
and 3). Benzaldehyde precursor 11 was prepared from 
commercially available 4-hydroxybenzaldehyde (10) by MOM 
protection (Scheme 2).  In parallel, the acetophenone building 
block 13 was accessed from 3,4-dimethoxyphenol (12). Claisen-
Schmidt aldol condensation of 11 and 13 proceeded smoothly 
to afford the key chalcone intermediate 14.4,14 Intramolecular 
mercury(II) acetate mediated oxidative cyclization1 produced 
the intermediate aurone 15 in high yield and subsequent acid-
mediated MOM deprotection afforded the desired natural 
product rugaurone A (1).   
 
Scheme 2 Synthesis of rugaurone A (1). 
Rugaurones B (2) and C (3) were prepared in a similarly 
efficient manner (Scheme 3). Starting from the commercially 
available hydroquinone 16, acetophenone 17 was synthesized 
in high yield.  Regioselective MOM protection of 17 afforded 18, 
which was condensed with the corresponding aldehydes 19-20 
under basic ethanolic conditions to give the required MOM 
protected chalcones 21-22 respectively. Subsequent oxidative 
cyclization with mercury(II) acetate in pyridine furnished the 
corresponding aurones 23-24 and MOM deprotection yielded 
the desired natural products rugaurones B (2) and C (3) 
 
Scheme 3 Synthesis of rugaurones B (2) and (3).   
Attention was next turned towards the preparation of the 
polymethoxyflavone 4 (Scheme 4).  
 
Scheme 4 Synthesis of polymethoxyflavone (4).  
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The synthesis commenced with the oxidation of benzaldehyde 
25 to phenol 26. Subsequent acylation furnished acetophenone 
27 in a good yield.15  A Claisen-Schmidt aldol condensation 
between 27 and aldehyde 28 furnished chalcone 292 and Algar-
Flynn-Oyamada oxidation4 yielded the corresponding flavonol 
scaffold 30. Methylation of 30 with methyl iodide in acetone 
under reflux then afforded the desire polymethoxyflavone 4 in 
an excellent yield. 
The divergent strategy employed in the synthesis of natural 
products 1-4 centres on the selective conversion of chalcone 
intermediates into aurones or flavones through the use of 
different oxidation procedures.  Attempts to rationalise this 
selectivity are complicated by uncertainties regarding the 
mechanisms of these oxidations.  It has been suggested that 
Algar-Flynn oxidation to form the flavone scaffold may proceed 
by direct intramolecular attack of the phenol oxygen on the 
alkene (presumably a conjugate addition process) or via an 
intermediate epoxide derivative;16-18 it is possible that 
stereoelectronic factors play a role in dictating the 
regioselectivity in both cases, though these are difficult to 
delineate18,19.  The exact mechanistic details of the mercury (II) 
acetate-mediated oxidative cyclisation of chalcones to aurones 
are also unknown.  Most evidence points towards a mechanism 
which involves formation and cyclisation of an aryloxy-mercury 
(II) acetate species,20-23 rather than an electrophilic-addition 
pathway (involving activation of the alkene bond by the 
mercury species and hydroxyl participation)20.  It has been 
suggested that 5-membered ring formation from the aryloxy-
mercury (II) acetate species (which leads to the aurone scaffold) 
is favoured over 6-ring formation (which leads to the flavone 
scaffold) due to steric effects.23   
In conclusion, the first total syntheses of the natural products 
rugaurones A–C (1–3) and polymethoxyflavone (4) was 
achieved. A divergent synthetic strategy was employed,13 which 
allowed access to these biologically interesting compounds in an 
expedient and step-efficient fashion from readily available 
starting materials. Notably, multi-milligram quantities of all four 
natural products were generated, which should provide ample 
material for screening in biological assays. The divergent 
strategy is currently being applied to the synthesis of unnatural 
analogues of compounds 1-4 to allow the sampling of novel 
chemical space around these biologically relevant structures.  
This work, together with the results of biological screening 
investigations, will be reported in due course. 
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